[HTML][HTML] 甘草酸: 一种治疗新型冠状肺炎的潜在药物
葛孚晶， 曾晨鸣， 严芳洁， 钱美佳， 王伟华， 罗沛华… - 药学学报, 2021 - html.rhhz.net
… Therefore, the potential application of glycyrrhizic acid as COVID-19 treatment should be …
增, COVID-19的治疗方案仍很大程度上参考SARS冠状病毒(SARS-CoV) 的治疗经验.自COVID-19…
增, COVID-19的治疗方案仍很大程度上参考SARS冠状病毒(SARS-CoV) 的治疗经验.自COVID-19…
[PDF][PDF] 维生素D 在降低COVID-19 风险中的作用: 文献综述
WB Grant - doctoryourself.com
… These symptoms are associated with a cytokine storm syndrome. The aim of this letter is to
… protective and therapeutic effects against COVID-19. For that reason, COVID-19 infection-…
… protective and therapeutic effects against COVID-19. For that reason, COVID-19 infection-…
[PDF][PDF] COVID-19 患者外周血单个核细胞lncRNA 相关ceRNA 调控网络的生物信息学分析
尤红俊， 任淑婷， 董梦雅 - 临床与病理杂志, 2022 - cdn.amegroups.cn
… the pathogenesis of COVID-19. Methods: Differential gene expression analysis about COVID-19…
expressed differentially statistically in PBMCs of COVID-19 patients. A ceRNA regulatory …
expressed differentially statistically in PBMCs of COVID-19 patients. A ceRNA regulatory …
巴瑞替尼在新型冠状病毒感染中对Ⅰ 型干扰素信号通路的影响.
梁婉欣， 张苏， 欧敏， 段炼， 张国良… - China Tropical …, 2022 - search.ebscohost.com
… Critical determinants of cytokine storm and type I interferon response in COVID-19
pathogenesis[J]. Clin Microbiol Rev, 2021, 34(3): e00299-e00220. [ 21 ] SA RIBERO M, JOUVENET …
pathogenesis[J]. Clin Microbiol Rev, 2021, 34(3): e00299-e00220. [ 21 ] SA RIBERO M, JOUVENET …
细胞因子风暴综合征和细胞因子释放综合征的研究进展
刘亮， 孟圆， 高全立 - 中国肿瘤临床, 2022 - cjco.cn
… (cytokine storm,CS)是一种累及全身的系统性炎症反应,可由多种诱因导致,由其发展的疾病包括
细胞因 子风暴综合征(cytokine storm syndrome,CSS)和细胞因子释放综合征(cytokine release …
细胞因 子风暴综合征(cytokine storm syndrome,CSS)和细胞因子释放综合征(cytokine release …
通过与SARS 和MERS 的比较探索COVID-19 远期并发症及防治措施
胡晶晶， 童瑾 - 基础医学与临床, 2020 - journal11.magtechjournal.com
… (MERS-CoV) infection: epidemiologyꎬ pathogenesis and clinical characteristics [J]. …
inflammatory cytokine storm: a major threat to human health[J]. J Interferon Cytokine Resꎬ …
inflammatory cytokine storm: a major threat to human health[J]. J Interferon Cytokine Resꎬ …
糖脂代谢在新型冠状病毒肺炎普通型和重型患者中的特点分析及比较
岳江， 周勇， 徐华， 刘文， 韩晓凤， 毛青… - 上海交通大学学报 …, 2021 - xuebao.shsmu.edu.cn
… 的36例COVID-19普通型患者和重症监护室(intensive care unit,ICU)的50例COVID-19 重型患者
… 从糖脂代谢角度初步分析COVID-19 普通型和重型患者的特点及患者入住ICU的相关因素.结果·…
… 从糖脂代谢角度初步分析COVID-19 普通型和重型患者的特点及患者入住ICU的相关因素.结果·…
[HTML][HTML] 最新产品价格查看产品价格
EA Teslow - promega.com.cn
… treatment strategy for critically ill COVID-19 patients 6,8 . … , may help assess prevalence of
COVID-19 disease and determine … ) COVID-19: Pathogenesis, cytokine storm and therapeutic …
COVID-19 disease and determine … ) COVID-19: Pathogenesis, cytokine storm and therapeutic …
[HTML][HTML] 炎症与氧化应激在急性肺损伤中的作用研究进展
朱钰珊， 彭学容， 范苏苏， 孙亚茹， 张旋 - Hans Journal of Biomedicine, 2023 - hanspub.org
… pathogenesis and no clear clinical cure. In recent years, it has been reported that inflammation
and oxidative stress are closely related to the development of ALI/ARDS. This paper …
and oxidative stress are closely related to the development of ALI/ARDS. This paper …
急性呼吸窘迫综合征肺气血屏障损伤及治疗的研究进展
周睿， 佘林君， 潘盼， 谢菲 - 解放军医学院学报, 2022 - xuebao.301hospital.com.cn
… ARDS 与肺气血屏障通透性在病毒感染诱 发COVID-19 并发ARDS 过程中,2019-nCoV 上 调
血管内皮生长因子和细胞黏附因子表达,破坏 肺多糖包被,增加屏障通透性[25];同时病毒对机 体固有…
血管内皮生长因子和细胞黏附因子表达,破坏 肺多糖包被,增加屏障通透性[25];同时病毒对机 体固有…